A Model for Monitoring Spontaneously Reported Medication Errors Using the Adjuvanted Recombinant Zoster Vaccine as an Example
A European legislation was put in place for the reporting of medication errors, and guidelines were drafted to help stakeholders in the reporting, evaluation, and, ultimately, minimization of these errors. As part of pharmacovigilance reporting, a proper classification of medication errors is needed...
Saved in:
| Main Authors: | Christophe Dessart, Fernanda Tavares-Da-Silva, Lionel Van Holle, Olivia Mahaux, Jens-Ulrich Stegmann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Advances in Pharmacological and Pharmaceutical Sciences |
| Online Access: | http://dx.doi.org/10.1155/2024/6435993 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence
by: Raunak Parikh, et al.
Published: (2023-12-01) -
An Exploratory Investigation of Representations of Herpes Zoster and Adjuvanted Recombinant Herpes Zoster Vaccination in a Sample of Fragile Adults in Italy
by: Francesco De Caro, et al.
Published: (2025-02-01) -
Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complicationsResearch in context
by: Ana Strezova, et al.
Published: (2025-05-01) -
Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine
by: Maria Costantino, et al.
Published: (2025-02-01) -
Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: A randomized, placebo-controlled trial
by: Diana Alexandra Echeverria Proano, et al.
Published: (2024-12-01)